GRFS
Grifols, SA

917
Loading...
Loading...
News
all
press releases
Should Value Investors Buy Grifols (GRFS) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·5d ago
News Placeholder
More News
News Placeholder
All You Need to Know About Grifols (GRFS) Rating Upgrade to Buy
Grifols (GRFS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·16d ago
News Placeholder
GRFS or NBIX: Which Is the Better Value Stock Right Now?
GRFS vs. NBIX: Which Stock Is the Better Value Option?
Zacks·24d ago
News Placeholder
Are Investors Undervaluing Grifols (GRFS) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·24d ago
News Placeholder
New Strong Sell Stocks for July 31st
CELZ, GRFS and WHR have been added to the Zacks Rank #5 (Strong Sell) List on July 31, 2025.
Zacks·1mo ago
News Placeholder
Will Strong Asceniv Sales Drive ADMA Biologics Further?
ADMA rides on record Asceniv sales and FDA-backed yield boost, but valuation concerns and EPS downgrades cloud its outlook.
Zacks·3mo ago
News Placeholder
ADMA Looks to Expand Asceniv's Label: Will This Boost Sales?
Zacks·3mo ago
News Placeholder
ADMA Stock Gains 17% in Three Months: Buy, Sell or Hold?
Zacks·3mo ago
News Placeholder
Grifols (GRFS) Is Up 2.47% in One Week: What You Should Know
Zacks·3mo ago
News Placeholder
Is Grifols (GRFS) Stock Undervalued Right Now?
Zacks·3mo ago

Latest GRFS News

View

Advertisement. Remove ads.

Advertisement. Remove ads.